Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study

Objective: Hydroxychloroquine has been proposed as a primary prophylactic agent against coronavirus disease 2019 (COVID-19). This study aimed to investigate if patients treated with hydroxychloroquine for a non-COVID-19 indication had a lower risk of verified infection with severe acute respiratory...

Full description

Bibliographic Details
Main Authors: Peter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, Nils Hoyer, Charlotte Suppli Ulrik, Lars Pedersen, Therese S. Lapperre, Zitta Barrella Harboe, Uffe Bodtger, Rasmus Dahlin Bojesen, Kjell E.J. Håkansson, Casper Tidemandsen, Karin Armbruster, Andrea Browatzki, Howraman Meteran, Christian Niels Meyer, Kristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Jens D. Lundgren, Tor Biering-Sørensen, Jens-Ulrik Jensen
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:International Journal of Infectious Diseases
Subjects:
Hydroxychloroquine
SARS-CoV-2
COVID-19
Prophylaxis
Epidemiology
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221004781

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221004781

Similar Items